share_log

Stoneridge Analyst Ratings

ストーンリッジアナリスト評価

Benzinga ·  2023/08/03 08:30
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/03/2023 Barrington Research Upgrades Market Perform → Outperform
05/26/2023 11.7% Stephens & Co. → $23 Reiterates Overweight → Overweight
05/04/2023 11.7% Stephens & Co. → $23 Reiterates → Overweight
03/02/2023 31.13% Stephens & Co. → $27 Reiterates → Overweight
05/11/2020 -2.87% B. Riley Securities $25 → $20 Maintains Neutral
02/28/2020 35.99% Stephens & Co. $36 → $28 Maintains Overweight
10/03/2018 69.99% Buckingham Research $37 → $35 Maintains Buy

What is the target price for Stoneridge (SRI)?

The latest price target for Stoneridge (NYSE: SRI) was reported by Barrington Research on August 3, 2023. The analyst firm set a price target for $0.00 expecting SRI to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Stoneridge (SRI)?

The latest analyst rating for Stoneridge (NYSE: SRI) was provided by Barrington Research, and Stoneridge upgraded their outperform rating.

When is the next analyst rating going to be posted or updated for Stoneridge (SRI)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stoneridge, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stoneridge was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.

Is the Analyst Rating Stoneridge (SRI) correct?

While ratings are subjective and will change, the latest Stoneridge (SRI) rating was a upgraded with a price target of $0.00 to $0.00. The current price Stoneridge (SRI) is trading at is $20.59, which is out of the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする